Cargando…

Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro

Pancreatic cancer is one of the most aggressive solid malignancies, as it has a 5-year survival rate of less than 10%. The growth and invasion of pancreatic cancer cells into normal tissues and organs make resection and treatment difficult. Finding an effective chemotherapy drug for this disease is...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dongchao, Shen, Hongzhang, Tian, Mengyao, Chen, Wangyang, Zhang, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066209/
https://www.ncbi.nlm.nih.gov/pubmed/35517401
http://dx.doi.org/10.7150/jca.65875